Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shelley Crary

Concepts (163)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vascular Malformations
8
2024
102
4.020
Why?
Blood Coagulation Disorders
4
2022
38
2.650
Why?
Kasabach-Merritt Syndrome
3
2024
5
1.940
Why?
Splenectomy
10
2018
34
1.670
Why?
Hemostasis
2
2024
59
1.570
Why?
Spherocytosis, Hereditary
6
2015
14
1.460
Why?
Sclerotherapy
3
2022
46
1.440
Why?
Hemangioendothelioma
3
2024
8
1.250
Why?
Hemophilia A
2
2024
25
0.970
Why?
Sarcoma, Kaposi
2
2023
75
0.930
Why?
Anticoagulants
3
2024
254
0.920
Why?
Child
27
2024
6931
0.830
Why?
Thrombosis
2
2024
250
0.810
Why?
Child, Preschool
20
2024
3953
0.780
Why?
Thrombelastography
1
2020
25
0.700
Why?
Anemia, Sickle Cell
5
2021
95
0.680
Why?
Sirolimus
2
2023
61
0.670
Why?
Bleomycin
2
2022
34
0.630
Why?
Adolescent
21
2024
6453
0.620
Why?
Autoimmune Lymphoproliferative Syndrome
1
2018
2
0.600
Why?
Antibiotics, Antineoplastic
1
2018
77
0.550
Why?
Purpura, Thrombocytopenic, Idiopathic
3
2024
24
0.530
Why?
Young Adult
12
2024
4075
0.530
Why?
Humans
38
2024
50419
0.500
Why?
Postoperative Complications
3
2014
1030
0.490
Why?
Hematinics
2
2013
13
0.460
Why?
Reticulocyte Count
2
2015
5
0.460
Why?
Anemia, Iron-Deficiency
2
2013
19
0.460
Why?
Female
23
2024
27053
0.450
Why?
Hemorrhage
4
2024
195
0.450
Why?
Male
23
2024
25866
0.440
Why?
Factor IX
2
2024
2
0.440
Why?
Hemophilia B
2
2024
5
0.440
Why?
Heart Transplantation
1
2018
366
0.440
Why?
Adult
13
2024
13561
0.420
Why?
Infant
12
2024
3648
0.410
Why?
Genetic Therapy
2
2024
120
0.400
Why?
Hematologic Diseases
2
2009
21
0.400
Why?
Ferric Compounds
1
2010
11
0.360
Why?
Retrospective Studies
11
2024
6274
0.340
Why?
Hypertension, Pulmonary
1
2011
123
0.330
Why?
Vascular Diseases
2
2009
73
0.320
Why?
Blood Flow Velocity
2
2020
99
0.320
Why?
Enoxaparin
1
2008
31
0.300
Why?
Thromboembolism
1
2006
54
0.250
Why?
Venous Thrombosis
1
2006
86
0.240
Why?
Risk Factors
5
2024
3712
0.240
Why?
Cardiovascular Diseases
1
2010
464
0.240
Why?
Osteomyelitis
1
2006
125
0.240
Why?
Prospective Studies
6
2023
2378
0.230
Why?
Hematology
1
2024
27
0.230
Why?
Hemoglobins
4
2015
112
0.220
Why?
Professional Role
1
2024
74
0.220
Why?
Postoperative Hemorrhage
1
2024
52
0.220
Why?
Factor VIII
1
2024
23
0.220
Why?
von Willebrand Diseases
1
2024
22
0.220
Why?
Treatment Outcome
6
2024
5265
0.220
Why?
Vascular Neoplasms
1
2023
17
0.220
Why?
Administration, Oral
2
2018
438
0.210
Why?
Anemia, Hemolytic, Congenital
2
2014
4
0.210
Why?
Autoantibodies
1
2024
114
0.210
Why?
Critical Illness
2
2020
302
0.210
Why?
Hemangioma
1
2023
83
0.200
Why?
Middle Aged
8
2024
12579
0.200
Why?
Databases, Factual
2
2024
676
0.190
Why?
Pupil
1
2021
29
0.190
Why?
Acute Pain
1
2021
11
0.190
Why?
Anxiety
1
2024
285
0.190
Why?
Mental Health
1
2024
225
0.190
Why?
Infusions, Intravenous
3
2013
212
0.180
Why?
Arterial Occlusive Diseases
1
2021
78
0.180
Why?
Blood Coagulation Tests
1
2020
20
0.180
Why?
Multiple Organ Failure
1
2020
48
0.170
Why?
Blood Coagulation
1
2020
59
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2021
224
0.160
Why?
Klippel-Trenaunay-Weber Syndrome
1
2019
3
0.160
Why?
Receptors, Fc
1
2019
8
0.160
Why?
Thrombopoietin
1
2019
9
0.160
Why?
Pain
2
2021
386
0.160
Why?
Vitiligo
1
2019
8
0.160
Why?
Depression
1
2024
577
0.160
Why?
Leukoencephalopathies
1
2019
14
0.150
Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.150
Why?
Nervous System Malformations
1
2019
17
0.150
Why?
Alopecia
1
2019
29
0.150
Why?
Recombinant Fusion Proteins
1
2019
186
0.150
Why?
Skin Neoplasms
1
2023
492
0.150
Why?
Fibrin Fibrinogen Degradation Products
1
2018
10
0.150
Why?
Fibrinogen
1
2018
33
0.150
Why?
Bilirubin
3
2015
41
0.150
Why?
Autoimmune Diseases
1
2019
78
0.150
Why?
Thrombocytopenia
1
2019
82
0.150
Why?
Follow-Up Studies
2
2021
2231
0.130
Why?
Cross-Sectional Studies
2
2011
1601
0.120
Why?
Aged
5
2024
9738
0.120
Why?
Hydroxyurea
1
2015
29
0.120
Why?
Prevalence
2
2024
967
0.120
Why?
Ankyrins
1
2014
9
0.120
Why?
Acute Chest Syndrome
1
2014
8
0.120
Why?
Diagnosis, Differential
1
2018
1029
0.120
Why?
Platelet Count
2
2019
65
0.110
Why?
Respiratory Tract Infections
1
2014
83
0.110
Why?
Iron-Dextran Complex
1
2013
3
0.110
Why?
Quality of Life
1
2019
850
0.100
Why?
Hematoma
1
2013
64
0.100
Why?
Protein Precursors
1
2011
43
0.090
Why?
Remission, Spontaneous
1
2011
24
0.090
Why?
Anemia, Hemolytic
1
2011
10
0.090
Why?
Natriuretic Peptide, Brain
1
2011
28
0.090
Why?
Tricuspid Valve
1
2011
23
0.090
Why?
Texas
1
2011
138
0.090
Why?
Early Diagnosis
1
2011
87
0.090
Why?
Glucaric Acid
1
2010
1
0.090
Why?
Infant, Newborn
3
2024
2752
0.090
Why?
Aged, 80 and over
2
2024
3233
0.090
Why?
Blood Cell Count
1
2010
39
0.090
Why?
Cholesterol, LDL
1
2010
41
0.090
Why?
Lipids
1
2010
151
0.080
Why?
C-Reactive Protein
1
2010
145
0.080
Why?
Ultrasonography
1
2011
434
0.080
Why?
Neoplasms
1
2019
1248
0.080
Why?
Medical Audit
1
2008
21
0.080
Why?
Time Factors
3
2024
2933
0.070
Why?
Cholesterol
1
2007
150
0.070
Why?
Acute Disease
1
2006
374
0.060
Why?
Terminology as Topic
1
2024
67
0.060
Why?
Vincristine
1
2023
82
0.050
Why?
Disease Management
1
2024
179
0.050
Why?
Ambulatory Care Facilities
1
2023
121
0.050
Why?
Genetic Vectors
1
2023
128
0.050
Why?
Alleles
1
2023
252
0.050
Why?
Genetic Testing
1
2023
120
0.050
Why?
Sclerosing Solutions
1
2022
15
0.050
Why?
Educational Status
1
2023
225
0.050
Why?
Registries
2
2015
565
0.050
Why?
P-Selectin
1
2021
31
0.050
Why?
Analgesics
1
2021
117
0.040
Why?
Pain Measurement
1
2021
271
0.040
Why?
Intensive Care Units, Pediatric
1
2020
175
0.040
Why?
United States
2
2024
5005
0.040
Why?
Clinical Trials as Topic
1
2021
488
0.040
Why?
Disease Susceptibility
1
2019
87
0.040
Why?
Incidence
1
2021
1027
0.040
Why?
Disease-Free Survival
1
2019
439
0.040
Why?
Length of Stay
1
2020
631
0.030
Why?
Survival Rate
1
2019
906
0.030
Why?
Immunosuppressive Agents
1
2018
227
0.030
Why?
Therapeutic Equivalency
1
2015
7
0.030
Why?
Solutions
1
2015
25
0.030
Why?
Capsules
1
2015
28
0.030
Why?
Antisickling Agents
1
2015
13
0.030
Why?
Decision Making
1
2018
271
0.030
Why?
Reticulocytes
1
2014
6
0.030
Why?
Physicians
1
2018
235
0.030
Why?
Risk Assessment
1
2019
1268
0.030
Why?
Forehead
1
2013
8
0.030
Why?
Laparoscopy
1
2015
172
0.030
Why?
Molecular Weight
1
2013
82
0.030
Why?
Syndrome
1
2011
236
0.020
Why?
Hemolysis
1
2009
28
0.020
Why?
Thrombocytosis
1
2007
4
0.020
Why?
Polycythemia
1
2007
9
0.020
Why?
Wounds and Injuries
1
2009
288
0.020
Why?
Crary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description